Medical News

RSS

Study explores inflammation of endothelial cells by exosomes from COVID-19 patients

In a new study, researchers revealed that the nucleotide-binding oligomerization domain-like receptors or NOD-like receptors family pyrin domain containing 3 (NLRP3) inflammasome is activated by the exosomes from plasma in COVID-19.

9 Feb 2022

Association between SARS-CoV-2 infection and several key respiratory and non-respiratory complications

Researchers assessed the intensity of association between SARS-CoV-2 infection and risks of various respiratory and non-respiratory complications.

9 Feb 2022

SPT Labtech paves the way for a new era of genomics liquid handling with firefly® launch

SPT Labtech today announced the launch of firefly®, an innovative liquid handling platform for next-generation sequencing (NGS) library preparation.

From SPT Labtech 9 Feb 2022

Integrated NHS and adult social care sector could improve care for all

Patients will receive better, more joined-up care under new plans announced today to improve the links between health and social care.

9 Feb 2022

Study explores adaptive immunity and neutralizing antibodies against SARS-CoV-2 variants post-immunization in cancer patients

Researchers have conducted a prospective, longitudinal cohort study to analyze COVID-19 immunity in patients with cancer.

9 Feb 2022

AI based home monitoring during COVID-19 pandemic

Researchers conducted an open, prospective pilot feasibility analysis through artificial intelligence (AI)-based platform to provide clinical decision support on COVID-19 outcomes.

9 Feb 2022

Surveillance for potentially zoonotic viruses in rodent and bat populations in an agricultural settlement in Ghana

In a new study, researchers investigated viruses in bats and rodents - key reservoir hosts for zoonotic viral pathogens, in a small agricultural community in Ghana.

9 Feb 2022

Causality of associations between maternal BMI and child adiposity

Researchers modified the MR study methodologies to ensure a bias-proof evaluation of the causal effect of maternal BMI on offspring adiposity.

9 Feb 2022

mRNA COVID-19 vaccines shown to provide high level of protection against severe SARS-CoV-2 omicron infection

Scientists have recently studied the duration of protection provided by mRNA-based COVID-19 vaccines against symptomatic omicron infection, and associated severity and mortality.

9 Feb 2022

Effectiveness of COVID-19 vaccination 9 months post-vaccination for the population of Sweden

Researchers looked at the efficiency of COVID-19 vaccines in preventing infection, hospitalization, and death in the general population of Sweden over the first nine months following vaccination.

9 Feb 2022

Study finds strong evidence of extensive SARS-CoV-2 infection of white-tailed deer

The scientists tested samples collected from free-living and confined deer in Iowa to see if infection and subsequent transmission of SARS-CoV-2 in deer happens in nature.

9 Feb 2022

Polio, chickenpox, measles, now covid. It’s time to consult history on school vaccine mandates

The rapid spread of omicron across the nation — and the finding that vaccines continue to provide strong protection against severe disease — brings covid-19 one step closer, perhaps, to truly earning its place on the list of diseases that have been tamed by vaccines.

9 Feb 2022

Study finds 50% increase in hospitalizations for alcoholic hepatitis in early months of the pandemic

In new research published in Liver International, researchers at Henry Ford Health System have found that people hospitalized for alcoholic hepatitis – a life threatening liver disease fueled by alcohol use – increased a staggering 50 percent in the early months of the COVID-19 pandemic.

9 Feb 2022

30-year-old cancer drug could get another shot, study says

A study by Virginia Commonwealth University Massey Cancer Center researchers published in today's print edition of Molecular Cancer Therapeutics shows that triplatin is effective against triple negative breast cancer, which is the most aggressive form of breast cancer and has few targeted therapies.

9 Feb 2022

Danish study of long COVID in teens

As an aftermath of the extended lockdowns and social distancing restrictions, Coronavirus disease 2019 (COVID-19) has impacted the quality of life of children and adolescents worldwide, not only physically due to the infection, but also mentally. A high level of anxiety and depression has been reported among pediatric patients and adolescents, many of whom were deprived of social interaction with peers during the pandemic.

9 Feb 2022

Research provides insights into the effects of Covid-19 lockdown on early development

An international consortium with researchers from 13 countries has investigated the impact of Covid-19 related social isolation measures on 2,200 young infants and toddlers between 8 and 36 months of age.

9 Feb 2022

Antarctic soil sample from 2018 adds to the enigma of the COVID-19 pandemic

The origin of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) has long been debated among scientists. However, prior research found early genetic material of a unique SARS-CoV-2 variant from the soil on King George Island, Antarctica between 24 December 2018 and 13th January 2019.

9 Feb 2022

Reviewing breath biomarkers for inflammatory respiratory diseases

The prevalence of inflammatory airway diseases such as lung cancer, chronic obstructive pulmonary disease (COPD) and asthma is on the rise internationally, placing strain on health systems around the world. Lung cancer is the leading cause of death of all cancers.

From Owlstone Medical Ltd 8 Feb 2022

Study highlights benefit of mRNA boosters for SARS-CoV-2 following different initial vaccine types

A study by researchers from the United Kingdom finds no difference in the protection offered by mRNA vaccine boosters against the severe acute respiratory syndrome coronavirus 2 (SARS‑CoV‑2) when comparing those that have received BioNTech/Pfizer vaccine as a primary course to those that have received Oxford/AstraZeneca.

8 Feb 2022

Old FDA-approved drug may protect against lung injury and blood clots in severe COVID-19

An FDA-approved drug that has been in clinical use for more than 70 years may protect against lung injury and the risk of blood clots in severe COVID-19 and other disorders that cause immune-mediated damage to the lungs, according to a preclinical study from researchers at Weill Cornell Medicine and Cold Spring Harbor Laboratory.

8 Feb 2022

Medical News

Study explores inflammation of endothelial cells by exosomes from COVID-19 patients

Association between SARS-CoV-2 infection and several key respiratory and non-respiratory complications

SPT Labtech paves the way for a new era of genomics liquid handling with firefly® launch

Integrated NHS and adult social care sector could improve care for all

Study explores adaptive immunity and neutralizing antibodies against SARS-CoV-2 variants post-immunization in cancer patients

AI based home monitoring during COVID-19 pandemic

Surveillance for potentially zoonotic viruses in rodent and bat populations in an agricultural settlement in Ghana

Causality of associations between maternal BMI and child adiposity

mRNA COVID-19 vaccines shown to provide high level of protection against severe SARS-CoV-2 omicron infection

Effectiveness of COVID-19 vaccination 9 months post-vaccination for the population of Sweden

Study finds strong evidence of extensive SARS-CoV-2 infection of white-tailed deer

Polio, chickenpox, measles, now covid. It’s time to consult history on school vaccine mandates

Study finds 50% increase in hospitalizations for alcoholic hepatitis in early months of the pandemic

30-year-old cancer drug could get another shot, study says

Danish study of long COVID in teens

Research provides insights into the effects of Covid-19 lockdown on early development

Antarctic soil sample from 2018 adds to the enigma of the COVID-19 pandemic

Reviewing breath biomarkers for inflammatory respiratory diseases

Study highlights benefit of mRNA boosters for SARS-CoV-2 following different initial vaccine types

Old FDA-approved drug may protect against lung injury and blood clots in severe COVID-19

How Programmable Nanobiology Could Drive the Fifth Industrial Revolution

Dr. Anthony Grice

Building quality into drug development for safer, faster medicines

Latest News